Literature DB >> 33432854

5,926 hysterectomies: complications described by Clavien-Dindo classification.

Rodrigo I Alliende1, Álvaro M Carrasco1, Marco Levancini2,3, Elias Kovoor4, Rodrigo A Guzmán-Rojas2,3,5, Ignacio Miranda-Mendoza2,3,5.   

Abstract

Hysterectomy is the most common major gynaecological surgery. Due to its high volume, the analysis of its results is relevant. The objective of this study was to describe intraoperative complications and reoperations, for both benign and malignant causes, using the Clavien-Dindo classification (approved by local ethics committee, number 100220). Between 2000 and 2019, 5926 elective hysterectomies were performed, of which 90.2% were for benign aetiology and 9.8% for malignant causes. The abdominal route was 52.7%, vaginal 40.1% and laparoscopic 7.2%. Intraoperative complications and reoperations (grade III Clavien-Dindo) were 4% and 2.1%, respectively. Oncological surgery had significantly more intraoperative complications (10% vs. 3.4%) and reoperations (3.6% vs. 1.9%) than benign procedures. Noteworthy, intraoperative complications required a new operation in only 3.4% for malignant and 2.8% for benign surgery. Our data showed the relevance of detecting and rectifying intraoperative complications during surgery, which consequently leads to a lower reoperation rate, minimising postoperative morbidity and mortality for patients.Impact StatementWhat is already known on this subject? The surgical complications of hysterectomy, both intraoperative and postoperative, are extensively described. However, this information is not well systematised, in which elective and emergency surgery are mixed. In addition to the above, there are few documents comparing the results of hysterectomies due to benign versus malignant causes.What the results of this study add? Using the Clavien-Dindo classification, this study adds an organised description of intraoperative complications and reoperations of hysterectomy in the context of elective surgery. In addition, it provides information on the comparison between surgery for benign versus malignant causes, as well as information on intraoperative complications requiring a new operation.What the implications are of these findings for clinical practice and/or further research? These findings provide clear and orderly data about the risks of elective hysterectomy and showed the relevance of detecting and rectifying intraoperative complications during the procedure. This is useful for specialists to preoperatively identify the risks for each hysterectomy group and provide their patients with more detailed information during informed consent.

Entities:  

Keywords:  Clavien–Dindo classification; Hysterectomy; complication; reoperation

Mesh:

Year:  2021        PMID: 33432854     DOI: 10.1080/01443615.2020.1835843

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

Review 1.  Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality.

Authors:  Salvatore Giovanni Vitale; Rafał Watrowski; Fabio Barra; Maurizio Nicola D'Alterio; Jose Carugno; Thozhukat Sathyapalan; Ilker Kahramanoglu; Enrique Reyes-Muñoz; Li-Te Lin; Bulent Urman; Simone Ferrero; Stefano Angioni
Journal:  Diagnostics (Basel)       Date:  2022-05-09

2.  Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients.

Authors:  C Fotopoulou; J Sehouli; R Armbrust; R Chekerov; S Sander; M Biebl; S Chopra; Jonathan Krell; Natasha Rinne; Katherine Nixon
Journal:  Arch Gynecol Obstet       Date:  2021-10-01       Impact factor: 2.493

3.  Comparing compliance with the WHO surgical safety checklist and complication rates in gynecologic surgery between day and night shifts.

Authors:  Bekos Christine; Bodner-Adler Barbara; Sonja Zehetmayer; Umek Wolfgang
Journal:  Arch Gynecol Obstet       Date:  2022-05-27       Impact factor: 2.493

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.